Fureman, I; Meyers, K; McLellan, A T et al. (1997) Evaluation of a video-supplement to informed consent: injection drug users and preventive HIV vaccine efficacy trials. AIDS Educ Prev 9:330-41
|
Davis, R F; Metzger, D S; Meyers, K et al. (1995) Long-term changes in psychological symptomatology associated with HIV serostatus among male injecting drug users. AIDS 9:73-9
|
Meyers, K; Metzger, D S; McLellan, A T et al. (1995) Will preventive HIV vaccine efficacy trials be possible with female injection drug users? J Acquir Immune Defic Syndr Hum Retrovirol 10:577-85
|
Meyers, K; Metzger, D S; Navaline, H et al. (1994) HIV vaccine trials: will intravenous drug users enroll? Am J Public Health 84:761-6
|
Cohen, E; Navaline, H; Metzger, D (1994) High-risk behaviors for HIV: a comparison between crack-abusing and opioid-abusing African-American women. J Psychoactive Drugs 26:233-41
|
Zanis, D A; Metzger, D S; McLellan, A T (1994) Factors associated with employment among methadone patients. J Subst Abuse Treat 11:443-7
|
Frank, I; Fishman, N (1994) Epidemiology and clinical manifestations of human immunodeficiency virus infection. Semin Roentgenol 29:230-41
|
Metzger, D S; Woody, G E; McLellan, A T et al. (1993) Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 6:1049-56
|
Watkins, K E; Metzger, D; Woody, G et al. (1993) Determinants of condom use among intravenous drug users. AIDS 7:719-23
|
DePhilippis, D; Metzger, D S; Woody, G E et al. (1992) Attitudes toward mandatory human immunodeficiency virus testing and contact tracing. A survey of intravenous drug users in treatment. J Subst Abuse Treat 9:39-42
|
Showing the most recent 10 out of 11 publications